Searching for ways to continue its growth trajectory, the senior management team has decided to pursue a strategic acquisition. Management remains strongly committed to keeping the business focused on cardiovascular and metabolic diseases. Therefore, they believe targeting a smaller company that offers a complementary product line and capabilities within the cardiovascular segment is the best strategy. That said, however, management is feeling the pressure for growth so they are open to acquiring other diverse sources of revenue beyond the complementary product line in the cardiovascular space or a company that expands their global footprint. You should view a complementary product line and capabilities in the cardiovascular space as the primary goal of the acquisition (must have), but where other diverse sources of revenue or geographic regions would be an added secondary goal if available (nice to have). Beyond these